Taken from Deborah Birx proposes weekly testing for every cow in America to stop bird flu
Since leaving government work, Birx has already earned millions of dollars in the private sector, and has found herself quite a few lucrative opportunities in the Pharma space.
Birx now sits on the advisory board of BGR, one of the most powerful lobbying firms in Washington D.C. Their Pharma client roster includes the likes of Pfizer, Abbott Labs, GSK, and Johnson & Johnson, to name a few.
Birx is also the CEO of a publicly traded company called Armata Pharmaceuticals, through which she was granted about 275,000 shares. As of Wednesday, her holdings in Armata are valued at about $728,750. Birx also earns a base salary of $525,000 per year, and she can earn a massive performance bonus based on the value of the company.
Armata is 70% owned by another publicly traded company called Innoviva, which describes itself as a “Healthcare Royalty and Asset Management” company. Innoviva’s top shareholders include BlackRock and Vanguard, which, through their clients’ positions, control about 25% of Innoviva.
Birx also holds several additional board seats in startup and seasoned Pharma endeavors, some of which may stand to acquire significant government funding in the event of a manufactured pandemic scenario.
alicespringstomind 